Whole-body Diffusion MRI for Staging, Response Prediction and Detecting Tumor Recurrence in Patients With Ovarian Cancer

NACompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Ovarian Carcinoma
Interventions
OTHER

Whole body diffusion-weighted MRI

"MRI is a technique based on magnetic fields and does not require the use of ionizing radiation. Although there are no known side effects associated with MRI, a few precautions should be taken because of the 3T magnetic field. This implicates that all metal and magnetized objects must be removed from the patient before entering the MRI room. Patients with a pacemaker, a cardiac defibrillator or other implanted conductors/prostheses are for this reason not eligible for the study.~During the whole body MRI examination, an intravenous contrast agent will be administered. In most cases, patients do not experience any discomfort and the use of this contrast agent is part of the clinical routine.~During the whole body MRI examinations, a bowel relaxing injection (Buscopan) is also needed to reduce movement of the intestines."

Trial Locations (1)

3000

University Hospitals UZ Leuven, Gasthuisberg, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT01657747 - Whole-body Diffusion MRI for Staging, Response Prediction and Detecting Tumor Recurrence in Patients With Ovarian Cancer | Biotech Hunter | Biotech Hunter